Differences in schizophrenia treatments by race and ethnicity—analysis of electronic health records

Autor: Candice Medina, Ayooluwa Akinkunmi, Nevaeh Bland, Eva Velthorst, Avi Reichenberg, Vahe Khachadourian, Amirhossein Modabbernia, Magdalena Janecka

Publikováno v: Schizophrenia, Vol 10, Iss 1, Pp 1-8 (2024)

Abstract Racial disparities in prescriptions of anti-psychotics have been highlighted before. However, (i) the evidence on other medications, including anti-depressant or mood stabilizing medications is lacking, and (ii) the role of potentially confo

Externí odkaz: https://doaj.org/article/e15fdb1aa3394cc897d7393638eb4859

Associations between early life exposure to manganese and developmental trajectories of executive functions

Autor: L. Mascaro, Roberto Gasparotti, Cheuk Y. Tang, Robert O. Wright, Elza Rechtman, Demetrios M. Papazaharias, Esmeralda Navarro, Donald R. Smith, Giuseppa Cagna, Donatella Placidi, Roberto Lucchini, Megan K. Horton, Manish Arora, Christine Austin, Avi Reichenberg, Claudia Ambrosi, Elena Colicino

Publikováno v: ISEE Conference Abstracts. 2021

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8a78306c39435f3cd19b8c1d89bd7735
https://doi.org/10.1289/isee.2021.p-074

OCD symptom severity and comorbid psychiatric diagnoses in a Swedish genetic epidemiological obsessive-compulsive disorder cohort

Autor: Behrang Mahjani, Christina M. Hultman, Christina Gustavsson Mahjani, Dorothy E. Grice, Joseph D. Buxbaum, Sven Sandin, Avi Reichenberg

BackgroundWe have established an epidemiological obsessive-compulsive disorder (OCD) cohort in Sweden. Individuals contributed DNA for genotyping and sequencing and also completed a Swedish translation of the Obsessive-Compulsive Inventory-Revised (O

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::546279efbf7725d262aca611f85058d4
https://doi.org/10.1101/2021.06.28.21259652

An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients

Autor: Tolga Uz, Mitul A. Mehta, Sukhi Shergill, Frank Ogrinc, Lorena Valdearenas, James Gilleen, Max Tsai, Steve C.R. Williams, Yakub Farah, Gez Lahu, Sarah Kerins, Avi Reichenberg, Cate Davison

Publikováno v: Psychopharmacology
Gilleen, J, Farah, Y, Davison, C, Kerins, S, Valdearenas, L, Uz, T, Lahu, G, Tsai, M, Ogrinc, F, Reichenberg, A, Williams, S C, Mehta, M A & Shergill, S S 2018, ' An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients ', Psychopharmacology, vol. 0, no. 0, pp. 1-11 . https://doi.org/10.1007/s00213-018-5134-y

Rationale Schizophrenia is associated with impairments in cognitive functioning yet there are no approved drugs to treat these deficits. Objectives Based on animal models, we investigated the potential for roflumilast, a selective inhibitor of phosph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1d51d1938ef9c4ac3e9cd298c03f28
https://doi.org/10.1007/s00213-018-5134-y

Initial severity and efficacy of risperidone in autism: Results from the RUPP trial

Autor: Stefan Leucht, Yair Goldberg, Alexander Kolevzon, Stephen Z. Levine, Arad Kodesh, Avi Reichenberg, Toshi A. Furukawa

Publikováno v: European Psychiatry. 32:16-20

BackgroundRisperidone is a common psychopharmacological treatment for irritability in autism spectrum disorder (ASD). It is not well-established how effective risperidone is across the initial symptom severity range. This study aims to examine the in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb8322ad5173069d71d113cd6431a62c
https://doi.org/10.1016/j.eurpsy.2015.11.004